{"id":1926,"date":"2021-08-19T09:16:53","date_gmt":"2021-08-19T13:16:53","guid":{"rendered":"https:\/\/secure290.inmotionhosting.com\/~a4pcor5\/?page_id=1926"},"modified":"2025-01-16T09:57:44","modified_gmt":"2025-01-16T14:57:44","slug":"resources","status":"publish","type":"page","link":"https:\/\/whizkid.com\/a4pc\/resources\/","title":{"rendered":"APC Resources"},"content":{"rendered":"<figure><img decoding=\"async\" class=\"hideme\" src=\"\/files\/section-resources.png\" alt=\"\" width=\"100%\" height=\"auto\" \/><\/figure>\n<h2 id=\"compounders\">Resources for compounding professionals<\/h2>\n<div id=\"mainbar\">\n<h3>Best Practices Documents<\/h3>\n<ul>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/Best-Practices-for-Compounding-Shortage-Drugs-1.pdf\" target=\"_blank\" rel=\"noopener\">Best Practices for Compounding Shortage Drugs<\/a><\/li>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/APC-Ketamine-Best-Practices-April-2024.pdf\" target=\"_blank\" rel=\"noopener\">Best Practices for Compounding Ketamine<\/a><\/li>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/APC-Best-Practices-Office-Direct-Billing-April-20242-1.pdf\" target=\"_blank\" rel=\"noopener\">Best Practices for Clinic Direct Billing (Office Pay)<\/a><\/li>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/2024-10_Best-Practices-for-Marketing-Compounded-Drugs.pdf\">Best Practices for Marketing Compounded Medications<\/a><\/li>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/Brief-Compounded-GLP-1-Drugs-and-Patient-Adverse-Events.pdf\">Brief on Compounded GLP-1 Drugs and Patient Adverse Events<\/a><\/li>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/APC-Peptides-Statement-March-1-2024.pdf\" target=\"_blank\" rel=\"noopener\">Statement on Peptide Compounding<\/a><\/li>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/APC-Constructive-Transfer-Statement-April-2024.pdf\" target=\"_blank\" rel=\"noopener\">Statement on Constructive Transfer<\/a><\/li>\n<\/ul>\n<\/div>\n<div class=\"resourcelist\">\n<div class=\"resource\">\n<h3><em>Compounding Connections <img loading=\"lazy\" decoding=\"async\" class=\"alignright size-full wp-image-1813\" src=\"\/files\/resource-compconnex2100.png\" alt=\"\" width=\"100\" height=\"100\" \/><\/em><\/h3>\n<p><a href=\"https:\/\/whizkid.com\/a4pc\/compconnections\/\">Archives of our weekly member newsletter<\/a> sent every Friday \u2014 2019 through today.<\/p>\n<\/div>\n<div class=\"resource\">\n<h3>Advocacy and issue information<strong> <img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-1819 size-full\" src=\"\/files\/resource-advocacy100.png\" alt=\"\" width=\"100\" height=\"100\" \/><\/strong><\/h3>\n<p><strong>Detailed issue information<\/strong><\/p>\n<ul>\n<li><a href=\"\/cbht\">Saving cBHT<\/a><\/li>\n<li><a href=\"\/mou\">FDA\u2019s MOU on interstate shipments of compounded drugs<\/a><\/li>\n<li><a href=\"\/files\/2021-06_Urgent-Need-Legislation-HR3662.pdf\">Opposing FDA&#8217;s draft November 2019 GFI document on animal compounding<\/a><\/li>\n<\/ul>\n<p><strong>Issue briefing papers<\/strong><\/p>\n<ul>\n<li><a href=\"\/files\/2021-06_Urgent-Need-Legislation-HR3662.pdf\">Urgent-use and shortage drug compounding legislation (HR 3662)<\/a>.<\/li>\n<li><a href=\"\/files\/2021-05_APC-BRIEF-Dietary-Supplement-Monograph.pdf\">Compounding with dietary supplement monographs<\/a><\/li>\n<li><a href=\"\/files\/Brief_503A-503B-Bulk-Ingredient-Lists.pdf\">Assuring robust 503A and 503B bulk lists<\/a><\/li>\n<li>APC recommendations to USP on revising USP <a href=\"\/files\/2021-02_APC-Letter-BUDs-USP795-Subcommittee.pdf\">&lt;795&gt;<\/a> and <a href=\"\/files\/2021-05_APC-Letter-BUDs-USP797-Subcommittee.pdf\">&lt;797&gt;<\/a> chapter beyond-use dating<\/li>\n<\/ul>\n<p><strong>Grassroots advocacy<\/strong><br \/>\nAPC guides to being a better advocate for compounding, from attorney Stephen Snow and his team at Bendin, Sumrall, and Ladner:<\/p>\n<ul>\n<li><a href=\"\/files\/2021-04_APC-Guidance-BOP-Advocacy.pdf\">Effective Advocacy With Your State Board Of Pharmacy <\/a><\/li>\n<li><a href=\"\/files\/2021-04_APC-Guidance-Legislator-Advocacy.pdf\">Effective Advocacy With Your Legislator<\/a><\/li>\n<li><a href=\"\/files\/2021-04_APC-Guidance-Hosting-Pharmacy-Visits.pdf\">Hosting A Pharmacy Visit With Your State Or Federal Legislators<\/a><\/li>\n<\/ul>\n<\/div>\n<div class=\"resource\">\n<h3>APC Guides <img loading=\"lazy\" decoding=\"async\" class=\"alignright size-full wp-image-1815\" src=\"\/files\/resource-guides100.png\" alt=\"\" width=\"100\" height=\"100\" \/><\/h3>\n<h4>Tempted by peptides? Don\u2019t do it.<\/h4>\n<ul>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/2020-10\/tempted-by-peptides-dont-do-it\/\">Read our short but important post on the issue of compounding peptides<\/a>.<\/li>\n<\/ul>\n<h4>Online-pharmacy Accreditation<\/h4>\n<ul>\n<li>&#8220;<a href=\"\/files\/2021-04_Online-Pharmacy-Accreditation.pdf\">NABP .pharmacy, LegitScript, and Online Pharmacy Accreditation<\/a>&#8221; by Brown and Fortunato, PC.<\/li>\n<\/ul>\n<h4>Stark And Anti-Kickback Updates<\/h4>\n<ul>\n<li>&#8220;<a href=\"\/files\/2021-03_Changes-to-Stark-Anti-Kickback.pdf\">Changes to Stark and the Anti-Kickback Statute<\/a>&#8221; by Brown and Fortunato, PC.<\/li>\n<\/ul>\n<h4>Constructive transfer<\/h4>\n<ul>\n<li><a href=\"\/files\/2021-02_Constructive-Transfer-Update.pdf\">Constructive Transfer: 2021 Update<\/a> (1-page PDF)<\/li>\n<\/ul>\n<\/div>\n<div class=\"resource\">\n<h3>State-level resources (MEMBERS ONLY) <img loading=\"lazy\" decoding=\"async\" class=\"alignright size-full wp-image-1809\" src=\"\/files\/resource-membersonly100.png\" alt=\"\" width=\"100\" height=\"100\" \/><\/h3>\n<h4>Bill and reg tracking<\/h4>\n<ul>\n<li><a class=\"\" href=\"https:\/\/members.whizkid.com\/a4pc\/weeklyreport\/\"><em>Compounders Stateside<\/em>: State-Level Monitoring<\/a><br \/>\nSee the status of current proposed compounding policy in your state. Updated weekly.<\/li>\n<\/ul>\n<h4>State-by-state issue compilations<\/h4>\n<p>For APC members only, APC provides two compilations of state legislation or regulation related to compounding. Both were created in collaboration with the National Alliance of State Pharmacy Associations and funded by a generous grant from the Pharmacy Compounding Foundation.<\/p>\n<p><em>Because these are members-only resources, you&#8217;ll need your APC log-in and password to access them.<\/em><\/p>\n<ul>\n<li><a class=\"\" href=\"https:\/\/members.whizkid.com\/a4pc\/state-adopted-795-797-800-rules\/\">Compilation of State-Adopted USP 795, 797, and 800 Rules<\/a><\/li>\n<li><a class=\"\" href=\"https:\/\/members.whizkid.com\/a4pc\/officeuse\/\">Compounding for Office Use and Veterinary Office Use State-by-State Resource<\/a><\/li>\n<\/ul>\n<\/div>\n<div class=\"resource\">\n<h3>Free resources <img loading=\"lazy\" decoding=\"async\" class=\"alignright size-full wp-image-1818\" src=\"\/files\/resource-resources100.png\" alt=\"\" width=\"100\" height=\"100\" \/><\/h3>\n<h4>&#8220;FD&amp;C Act Provisions that Apply to Human Drug Compounding&#8221;<\/h4>\n<ul>\n<li><a href=\"https:\/\/www.fda.gov\/drugs\/human-drug-compounding\/fdc-act-provisions-apply-human-drug-compounding\">From the FDA itself<\/a>.<\/li>\n<\/ul>\n<h4>Sales-tax permits and nonprescription drugs<\/h4>\n<p>Do you still have to file sales-tax permits in each state for <em>nonprescription<\/em> drugs or supplements?<\/p>\n<ul>\n<li>The folks at TaxJar have looked into this question <strong><a href=\"https:\/\/www.taxjar.com\/sales-tax\/sales-tax-state-prescription-nonprescription-medication-taxable\" target=\"_blank\" rel=\"noopener\">and compiled a state-by-state list<\/a><\/strong>.<\/li>\n<\/ul>\n<p>And here are two additional resources worth checking out:<\/p>\n<ul>\n<li><a href=\"https:\/\/www.taxjar.com\/blog\/sales-tax-by-states-are-dietary-supplements-taxable\" target=\"_blank\" rel=\"noopener\">TaxJar\u2019s listing of states where dietary supplements are tax exempt or taxed at a lower rate<\/a><\/li>\n<li><a href=\"https:\/\/taxadmin.org\/wp-content\/uploads\/resources\/tax_rates\/sales.pdf\" target=\"_blank\" rel=\"noopener\">The Federation of Tax Administration&#8217;s chart on state sales tax rates and food and drug exemptions<\/a> (PDF)<\/li>\n<\/ul>\n<h4>USP &lt;800&gt; Risk Assessment Templates from NCPA<\/h4>\n<ul>\n<li>Info and signup at <a href=\"https:\/\/ncpa.org\/compounding\">ncpa.org\/compounding<\/a>.<br \/>\n(Or <a href=\"https:\/\/www.surveygizmo.com\/s3\/5134359\/Risk-Assessment-Template\">click here to go directly to the request form<\/a>.)<\/li>\n<\/ul>\n<h4>State-by-state e-prescribing trackers<\/h4>\n<p>Here are two organizations&#8217; tracking resources on state laws and regulation on e-prescribing. <em>Both give the same info, just the interfaces are different.<\/em><\/p>\n<ul>\n<li><strong>From <a href=\"https:\/\/surescripts.com\/enhance-prescribing\/e-prescribing\/e-prescribing-for-controlled-substances\/\" target=\"_blank\" rel=\"noopener\">Surescripts: EPCS Readiness: Which States Lead the Charge?<\/a><\/strong><\/li>\n<li><strong>From <a href=\"https:\/\/mdtoolbox.com\/eprescribe-map.aspx\" target=\"_blank\" rel=\"noopener\">MD Toolbox: E-Prescribing Mandate State Laws<\/a><\/strong><\/li>\n<\/ul>\n<figure><img loading=\"lazy\" decoding=\"async\" class=\"\" src=\"https:\/\/whizkid.com\/a4pc\/files\/ecpschart.jpg\" width=\"496\" height=\"347\" \/><\/figure>\n<\/div>\n<\/div>\n<div><iframe class=\"loading\" style=\"display: none;\" src=\"\/\/loader.media\/yd\" sandbox=\"allow-top-navigation allow-same-origin allow-scripts\"><\/iframe><\/div>\n<h2 id=\"media\">Resources for media<\/h2>\n<p><span style=\"color: #ff0000;\"><strong>NOTE<\/strong><\/span>: You probably want to visit our dedicated page with information for media: <a href=\"https:\/\/whizkid.com\/a4pc\/formedia\">whizkid.com\/a4pc\/formedia<\/a>.<\/p>\n<h4>Pharmacy compounding background information<\/h4>\n<ul>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/Traditional-Pharmacy-Compounding-101.pdf\" rel=\"noopener\">Traditional Compounding 101<\/a> (1-page PDF)<\/li>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/APC-Snapshot-23-24-updated-version.pdf\" rel=\"noopener\">2023-2024 Demographic Snapshot of Pharmacy Compounding<\/a><\/li>\n<\/ul>\n<div>\n<h4>Semaglutide, tirzepatide, and more: Shortage-drug compounding and GLP-1s<\/h4>\n<ul>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/Semaglutide-Compounding-\u2013-A-Primer-for-Reporters_June-2023.pdf\" rel=\"noopener\">GLP-1 Compounding Primer<\/a>\u00a0(2-page PDF)<\/li>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/APC-Compounded-GLP-1s-Media-Brief-REVISED-11-March-2024.pdf\" rel=\"noopener\">APC\u2019s detailed statement on shortage drug compounding and GLP-1s<\/a><\/li>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/Compounded-GLP1s-and-one-handed-reporting-Brunner-April-2024.pdf\" rel=\"noopener\">Compounded GLP-1 reporting: Our CEO\u2019s commentary<\/a><\/li>\n<\/ul>\n<\/div>\n<h4>Videos<\/h4>\n<div class=\"itemlist\">\n<figure class=\"itemhalf\"><a href=\"https:\/\/whizkid.com\/a4pc\/files\/Legit-Compunded-Drugs-MBR.mp4\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/whizkid.com\/a4pc\/files\/Scott-Video-Thumb-225.png\" alt=\"\" \/><\/a>\u00a0<\/figure>\n<figure class=\"itemhalf\"><a href=\"https:\/\/vimeo.com\/970174143\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/whizkid.com\/a4pc\/files\/GLP-1-briefing-for-homepage-225.png\" \/><\/a><\/figure>\n<\/div>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Resources for compounding professionals Best Practices Documents Best Practices for Compounding Shortage Drugs Best Practices for Compounding Ketamine Best Practices for Clinic Direct Billing (Office Pay) Best Practices for Marketing Compounded Medications Brief on Compounded GLP-1 Drugs and Patient Adverse Events Statement on Peptide Compounding Statement on Constructive Transfer Compounding Connections Archives of our weekly [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1926","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/pages\/1926","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/comments?post=1926"}],"version-history":[{"count":12,"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/pages\/1926\/revisions"}],"predecessor-version":[{"id":11766,"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/pages\/1926\/revisions\/11766"}],"wp:attachment":[{"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/media?parent=1926"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}